Patents by Inventor Fumie Abe

Fumie Abe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activity Modulator
    Publication number: 20220340659
    Abstract: The present invention relates to: an activity modulator which is a means for modulating the activity of CD300b-dependent phagocytosis; and medicine for the treatment or prevention of a disease or condition in which the activity is involved. The activity modulator comprises a CD300a-binding substance and modulates CD300b-dependent phagocytosis signals in a macrophage.
    Type: Application
    Filed: May 11, 2022
    Publication date: October 27, 2022
    Inventors: Akira Shibuya, Chigusa Oda, Fumie Abe, Satoshi Fujiyama
  • Regulatory T cell activator and use thereof
    Patent number: 11059888
    Abstract: A regulatory T cell activator including a substance that inhibits the binding between DNAX accessory molecule-1 (DNAM-1) and CD155.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: July 13, 2021
    Assignee: University of Tsukuba
    Inventors: Akira Shibuya, Kazuko Shibuya, Fumie Abe, Rei Hirochika, Genki Okumura
  • Activity Modulator
    Publication number: 20210188973
    Abstract: The present invention relates to: an activity modulator which is a means for modulating the activity of CD300b-dependent phagocytosis; and medicine for the treatment or prevention of a disease or condition in which the activity is involved. The activity modulator comprises a CD300a-binding substance and modulates CD300b-dependent phagocytosis signals in a macrophage.
    Type: Application
    Filed: November 28, 2018
    Publication date: June 24, 2021
    Inventors: Akira Shibuya, Chigusa Oda, Fumie Abe, Satoshi Fujiyama
  • Regulatory T Cell Activator and Use Thereof
    Publication number: 20190127462
    Abstract: A regulatory T cell activator including a substance that inhibits the binding between DNAX accessory molecule-1 (DNAM-1) and CD155.
    Type: Application
    Filed: April 19, 2017
    Publication date: May 2, 2019
    Inventors: Akira Shibuya, Kazuko Shibuya, Fumie Abe, Rei Hirochika, Genki Okumura